Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Dr Willmar Schwabe
Dr Willmar Schwabe
X
LinkedIn
Trending Articles
Beneo presents its taste-boosting excipient, galenIQ at CPHI 2024
galenIQ is designed to improve the flavour of oral solid dosage (OSD) forms for more patient-centric pharmaceuticals
Merck's MilliporeSigma cuts the ribbon on €290m US biosafety and analytical facility
The site will host biosafety testing, analytical development and cell banking manufacturing services
Seppic launches surfactant excipient for the optimisation of biological formulations
The ingredient is compatible with sensitive biologics, and aims to stabilise injectables for improved bioavailability, efficacy and shelf life
Strides Group launches CDMO OneSource Specialty Pharma at CPHI Milan
The newly integrated CDMO primarily specialises in the manufacture of biologics, drug-device combos and gelatin capsules
Johnson & Johnson completes V-Wave acquisition to support patients with heart failure
The strategic acquisition will bolster the pharma giant's MedTech offerings for patients with cardiovascular disease
Upcoming event
ISCC
15-18 October 2024 | Conference | Milan, Italy
See all
Related Content
Manufacturing
Reaping the benefits
Herbal pharmaceutical company Schwabe Group is gaining greater control, flexibility and visibility thanks to RS PMX MES from Rockwell Automation
Subscribe now